Klinik für Innere Medizin IIGastroenterologie, Hepatologie, Endokrinologie und Infektiologie

In clinical trials, new and often innovative therapies are tested for their efficacy and tolerability. Due to strict laws and regulations, the drugs in clinical trials are rigorously tested, which in turn ensures a high level of safety for you as a participant.

By participating in such a study, you will receive new and possibly more effective treatment options in addition to the already proven therapeutic options.

Further aspects are:

• Participation is free of charge, and you often receive a travel allowance for your participation
• Your participation makes an important contribution to medical progress and thus helps you and other patients
• Close-meshed examinations and detailed consultations, which is for your safety and can have a positive effect on your quality of life as well as the course of the disease
• Your participation in the study is voluntary and can be terminated at any time in consultation with your physician.

With any therapy, there is always the possibility of side effects occurring.
In order to optimize the safety of the participating patients, therefore:

• additional check-ups and examinations are carried out
• all possible side effects are systematically recorded and monitored.

In our study department, clinical studies are supervised from planning to completion. Physicians and study assistants work closely together.

Our aim is to ensure the best possible quality from both a medical and organizational perspective and to provide you with intensive support during your participation.

If you are interested in participating in a study, the first steps are as follows:

• You will be informed by an experienced physician about
  - the study contents
  - the individual procedure
  - therapy alternatives
  , among other things, and can decide after sufficient time for you to think about it.
  
• Our study staff
  - are available to answer your questions
  - will explain the further procedure to you
  - will arrange appointments with you for this purpose.

• The efficacy of a study drug is tested; for this purpose, there is often a placebo comparison group or it is compared with the approved standard therapy, for example.
• Assignment to one of the groups is done randomly (= randomization). In most studies, the rate of patients receiving the study drug is higher.
• In these studies, the study team also does not know which treatment arm they will be randomized to (= double-blind).
• Patients who receive placebo can sometimes switch to the study drug somewhat later.

The circumstances are individual for each study and are part of the detailed information you will receive from your physician.

We would like to give you an overview of the current clinical studies at our clinic via the links above. You will also find the contact details of our study assistants here.